Jackson Creek Investment Advisors’s Corcept Therapeutics CORT Stock Holding History

Jackson Creek Investment Advisors’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$731K	Buy	+6,383	New	+$385K	0.24%	178
2025 Q2	–	Sell	-21,591	Closed	-$2.47M	–	324
2025 Q1	$2.47M	Sell	21,591 -9,369	-30%	-$570K	0.78%	5
2024 Q4	$1.56M	Sell	30,960 -12,895	-29%	-$676K	0.47%	84
2024 Q3	$2.03M	Buy	43,855 +9,839	+29%	+$350K	0.6%	10
2024 Q2	$1.1M	Sell	34,016 -72	-0.2%	-$1.97K	0.4%	92
2024 Q1	$859K	Sell	34,088 -75	-0.2%	-$1.77K	0.31%	192
2023 Q4	$1.11M	Buy	+34,163	New	+$938K	0.43%	68

Other funds holding CORT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jackson Creek Investment Advisors's CORT Position: Q2 2026 in Review

Jackson Creek Investment Advisors opened a new position in Corcept Therapeutics (CORT) in Q2 2026: 6,383 shares worth $731K. The stake represents 0.24% of the portfolio and ranks #178 among its holdings. This is a return to the name: Jackson Creek Investment Advisors previously reported a position in CORT as recently as Q1 2025.

Jackson Creek Investment Advisors first reported a position in CORT in Q4 2023 and has held it in 7 quarters since. The position peaked at $2.47M in Q1 2025. 423 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

Jackson Creek Investment Advisors held 6,383 shares of Corcept Therapeutics worth $731K as of Q2 2026.
Corcept Therapeutics was a new Jackson Creek Investment Advisors position in Q2 2026.
Corcept Therapeutics made up 0.24% of Jackson Creek Investment Advisors's portfolio in Q2 2026, its #178 holding.
Jackson Creek Investment Advisors first reported a position in Corcept Therapeutics in Q4 2023 and has held it in 7 quarters since.
Jackson Creek Investment Advisors's Corcept Therapeutics position peaked at $2.47M in Q1 2025.
423 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Jackson Creek Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.